A positive serum MOG-IgG antibody test is pivotal for the diagnosis, setting MOGAD apart from MS and NMOSD, characterized by oligoclonal bands in cerebrospinal fluid (CSF) and AQP4 antibodies, respectively. The gene discussed is AQP4; the disease is myeloid sarcoma.